The regulatory body in Mexico has stated that advertisements on social media for the sale of electronic cigarettes or vaping devices are not the only means by which their sale can be detected. As a result, they have intensified their scrutiny of manufacturers and seized products.
The head of the Health Risk Protection Committee (Coepris) in Tamaulipas, Alberto Moctezuma Castillo, announced that they will be increasing their monitoring efforts due to complaints of illegal sales in other areas.
Last week we responded to citizens' complaints regarding the sale of electronic cigarettes in pharmacies. Although sales are prohibited, the pharmacies have obtained insurance and have begun the administrative process. Therefore, we are currently unable to provide more information," he commented.
The commissioner added that they also have information about the sale of these devices through social networks, which is the reason for their surveillance operation, particularly to prevent them from being sold to minors.
2FIRSTS will continue to track and report on this issue. Further updates will be available on the "2FIRSTSAPP". Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
